In addition, the Lats2/Sav1/YAP1/HIF1A signaling modulated by miR-103a-3p also controlled the glycolysis within CRC tumors through modulating glycolytic enzymes (e.g., HK2, PFK1, and LDHA) [90]. This evidence concerns the gene LATS2 and colorectal carcinoma.